Vitrakvi

larotrectinib · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for Vitrakvi, covering 2018-11-26 to 2026-08-04. Get the full timeline:

Most recent: EMA Authorised: Vitrakvi (larotrectinib sulfate) — Bayer AG